Fibrocell Science (OTCBB: FCSC.OB), FDA approves BLA for laViv, personalized aesthetic cell therapy
June 22nd, 2011
No comments
laVív® (azficel-T) is the first and only personalized aesthetic cell therapy approved by the FDA Read more…
Categories: BLA Approval, Fibrocell Science, NASDAQ: FSC.OB
